MERTK as a novel therapeutic target in head and neck cancer.
von Massenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schrock A, Bootz F, Brossart P, Kirfel J, Heasley L, Bragelmann J, Perner S
Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.